SecBot SecBot
15-12G ·Filed Mar 26, 2026

ZYXIQ

ZYNEX INC
BEARISH
Impact 8/10
Horizonimmediate Processed7mo ago SEC0001104659-26-035292
Deregistration
Actionable Insight ▼ Bearish

Prior public shareholders have been fully diluted; trading in ZYXIQ is likely to cease or move to limited OTC markets with no reporting. Monitor for any new public filings if the company re-emerges.

DirectionBearish
Confidencehigh
Horizonimmediate
Latest settled — T+1d
ZYXIQ ▲ 0.00% at T+1d
SHORT call ✗ call lost 0.00% · α vs SPY -0.36% · entry $0.0550 → $0.0550
Next anchor: T+5d due 7mo ago
Entry = T+0 close
Mar 26, 2026
via day close
T+1d
0.00%
call 0.00% · α -0.36%
$0.0550
settled 7mo ago
T+5d
Pending
due 7mo ago
T+20d
Pending
due 6mo ago
T+60d
Pending
due 4mo ago

Price Chart

Loading chart...

Executive Summary

Zynex, Inc. has terminated its SEC registration and suspended reporting obligations following a Chapter 11 bankruptcy restructuring. As of March 26, 2026, all prior common stock was cancelled and new shares were issued to the Plan Sponsor, leaving only one holder of record.

Key Facts

  • Zynex, Inc. filed Form 15-12G to terminate its SEC registration effective March 26, 2026.
  • The company emerged from Chapter 11 bankruptcy on March 26, 2026, after court confirmation of its reorganization plan on March 19, 2026.
  • All previously outstanding shares of common stock were cancelled as part of the bankruptcy restructuring.
  • New common stock was issued solely to the Plan Sponsor, reducing the number of holders of record to one.
  • The company is now privately held with no public reporting obligations.

Financial Impact

Complete equity wipeout for prior shareholders; no public valuation or liquidity post-restructuring.

equity valueshare countpublic floatliquidity

Risk Factors

  • Total loss of investment for former equity holders.
  • No transparency or financial reporting going forward.
  • Potential for zero recovery value for legacy shareholders.

Market Snapshot

Exchange
OTC
Sector
Electromedical & Electrotherapeutic Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
15-12G Filing (Primary)0001104659-26-035292
Document: 0001104659-26-035292-index-headers.html0001104659-26-035292
Document: 0001104659-26-035292-index.html0001104659-26-035292
Document: 0001104659-26-035292.txt0001104659-26-035292
2 reports for ZYXIQ
Performance horizon
Filters
Rows
Reports for ZYXIQ — sortable, filterable
TypeNow
Mar 26, 2026
30w ago
15-12G
BEARISH ★ 8/10
$0.0550 $0.0550· 0.00%▼ −0.36%—
Mar 19, 2026
31w ago
EFFECT
NEUTRAL ★ 4/10
$0.0715 $0.0700▼ −2.03%▼ −0.29%—
Showing 2 of 2

US Market Status

Market Open — Closes in 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 26, 2026